Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jong-Mu Sun

Showing results (61-70 of 303) with videos related to

Pageof 31
Sort By:
Scientific Reports|June 14, 2018
Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics ApproachSo Won Lee, Hyunjin Park, Ho Yun Lee, et al.
Cancer Research and Treatment|November 6, 2025
Real World Efficacy and Safety of First Line Chemo Immunotherapy in Extensive Stage Small Cell Lung Cancer and its association with molecular subtypeMiran Han, Sehhoon Park, Se-Hoon Lee, et al.
Head & Neck|December 30, 2014
Fate of patients with nasopharyngeal cancer who developed distant metastasis as first failure after definitive radiation therapyJi Hyun Chang, Yong Chan Ahn, Hyojung Park, et al.
Cancer Research and Treatment|May 23, 2023
Expanded Access Program Pralsetinib in Advanced Non-Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene RearrangementYoungkyung Jeon, Hyun Ae Jung, Sehhoon Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin According to Thymidylate Synthase Expression in Nonsquamous Non-Small-Cell Lung Cancer: A Biomarker-Stratified Randomized Phase II TrialJong-Mu Sun, Jin Seok Ahn, Sin-Ho Jung, et al.
Plos One|May 11, 2018
Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasisSoo Bin Park, Jung Mi Park, Seung Hwan Moon, et al.
Cancers|November 25, 2023
Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic AlterationsSoojin Jun, Sehhoon Park, Jong-Mu Sun, et al.
Cancer Research and Treatment|May 6, 2021
Long-term Survival in Non-Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive TreatmentHongsik Kim, Sehhoon Park, Hyun Ae Jung, et al.
Lung Cancer (Amsterdam, Netherlands)|March 6, 2012
ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosisHee Kyung Ahn, Boram Han, Su Jin Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|February 7, 2013
Real world impact of epidermal growth factor receptor mutation status on treatment patterns in patients with non-small cell lung cancerJong-Mu Sun, Sanjay Rampal, Genehee Lee, et al.
Pageof 31

Showing results (61-70 of 303) with videos related to

Sort By:
Pageof 31
Scientific Reports|June 14, 2018
Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics ApproachSo Won Lee, Hyunjin Park, Ho Yun Lee, et al.
Cancer Research and Treatment|November 6, 2025
Real World Efficacy and Safety of First Line Chemo Immunotherapy in Extensive Stage Small Cell Lung Cancer and its association with molecular subtypeMiran Han, Sehhoon Park, Se-Hoon Lee, et al.
Head & Neck|December 30, 2014
Fate of patients with nasopharyngeal cancer who developed distant metastasis as first failure after definitive radiation therapyJi Hyun Chang, Yong Chan Ahn, Hyojung Park, et al.
Cancer Research and Treatment|May 23, 2023
Expanded Access Program Pralsetinib in Advanced Non-Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene RearrangementYoungkyung Jeon, Hyun Ae Jung, Sehhoon Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin According to Thymidylate Synthase Expression in Nonsquamous Non-Small-Cell Lung Cancer: A Biomarker-Stratified Randomized Phase II TrialJong-Mu Sun, Jin Seok Ahn, Sin-Ho Jung, et al.
Plos One|May 11, 2018
Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasisSoo Bin Park, Jung Mi Park, Seung Hwan Moon, et al.
Cancers|November 25, 2023
Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic AlterationsSoojin Jun, Sehhoon Park, Jong-Mu Sun, et al.
Cancer Research and Treatment|May 6, 2021
Long-term Survival in Non-Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive TreatmentHongsik Kim, Sehhoon Park, Hyun Ae Jung, et al.
Lung Cancer (Amsterdam, Netherlands)|March 6, 2012
ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosisHee Kyung Ahn, Boram Han, Su Jin Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|February 7, 2013
Real world impact of epidermal growth factor receptor mutation status on treatment patterns in patients with non-small cell lung cancerJong-Mu Sun, Sanjay Rampal, Genehee Lee, et al.
Pageof 31